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Complex I (NADH ubiquinone oxidoreductase) in mamma-
lian mitochondria is an L-shaped assembly of 45 proteins. One
arm lies in the innermembrane, and theother extends about 100
Å into the matrix of the organelle. The extrinsic arm contains
binding sites for NADH, the primary electron acceptor FMN,
and seven iron-sulfur clusters that form a pathway for electrons
linking FMN to the terminal electron acceptor, ubiquinone,
which is bound in a tunnel in the region of the junction between
the arms. The membrane arm contains four antiporter-like
domains, energetically coupled to the quinone site and involved
in pumping protons from the matrix into the intermembrane
space contributing to the protonmotive force. Seven of the sub-
units, forming the core of the membrane arm, are translated
from mitochondrial genes, and the remaining subunits, the
products of nuclear genes, are imported from the cytosol. Their
assembly is coordinated by at least thirteen extrinsic assembly
factor proteins that are not part of the fully assembled complex.
They assist in insertion of co-factors and in building up the com-
plex from smaller sub-assemblies. One such factor, NDUFAF5,
belongs to the family of seven--strand S-adenosylmethionine-
dependent methyltransferases. However, similar to another
family member, RdmB, it catalyzes the introduction of a
hydroxyl group, in the case of NDUFAF5, into Arg-73 in the
NDUFS7 subunit of human complex I. Thismodification occurs
early in the pathway of assembly of complex I, before the forma-
tion of the juncture between peripheral and membrane arms.
Mammalian complex I (NADH:ubiquinone oxidoreduc-
tase)2 provides the entry point for electrons from NADH into
the mitochondrial electron transport chain, and couples elec-
tron transfer through the complex to the generation of the
proton-motive force across the inner membrane (1, 2). It is
composed of forty-five proteins with a combinedmass of about
1 MDa, assembled into an L-shaped complex, with one arm
embedded in the inner membranes of mitochondria and the
orthogonal, or peripheral, arm extending into the matrix of the
organelle (3–5). Seven of the subunits, named ND1-ND6 and
ND4L, are hydrophobic proteins that emanate from the mito-
chondrial genome (6, 7), and the remainder are encoded in the
nucleus and are imported into the organelle (8). The seven
mitochondrial-encoded subunits and seven of the nuclear-en-
coded subunits form the catalytic core of the enzyme (5, 9).
Electrons are transferred one at a time fromNADHthrough the
peripheral arm via the primary electron acceptor, FMN, and a
chain of seven iron-sulfur clusters, to the terminal acceptor,
ubiquinone. The oxidized ubiquinone binds in the region of the
juncture between the peripheral and membrane arms (9, 10),
and transfer of two electrons, one at a time, from the terminal
electron acceptor iron-sulfur cluster N2 to ubiquinone is cou-
pled to the ejection of four protons from the mitochondrial
matrix into the inter-membrane space, thereby contributing to
the generation of the proton motive force (11, 12). Proton
translocation takes place in the membrane arm, probably via
four antiporter folds. The remaining thirty supernumerary sub-
units are distributed between both arms. They have no direct
roles in catalysis, but at least one of them is involved in the
assembly of the complex (13). A structure of bovine complex I
at 5 Å resolution contains the fourteen core subunits modeled
on the basis of a high resolution structure of the bacterial com-
plex, and in addition the folds of twenty-two supernumerary
subunits have been recognized (5, 14). The structure of com-
plex I from Yarrowia lipolytica has been resolved in a similar
way (15).
The pathway of biogenesis of human complex I proceeds via
the formation of specific intermediate sub-complexes (16, 17),
and at least thirteen protein assembly factors, that are not con-
stituents of the mature functional enzyme, participate in this
process (13, 18). One of them, NDUFAF7, is a member of the
7-strand family of S-adenosylmethionine (SAM)-dependent
methyltransferases, and transfers methyl groups to the -NG-
and -NG-atoms of Arg-85 in subunit NDUFS2 at an early
stage in the assembly of complex I (19, 20). NDUFAF5 is
another member of the 7-strand family of SAM-dependent
methyltransferases. Its biochemical function is not known, but
pathogenic mutations in NDUFAF5 are associated with a defi-
ciency in complex I, and are found in patients with neonatal
mitochondrial disease (21) and Leigh syndrome (22, 23). The
introduction of these mutations intoDictyostelium produced a
defect in complex I similar to that observed in human cells (24).
Here, we describe investigations into the role of NDUFAF5 in
human mitochondria.
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Results
Sub-cellular Location of NDUFAF5—NDUFAF5 with a
C-terminal FLAG tag was found uniquely in the mitochondria
of human 143B cells (Fig. 1), in agreement with earlier experi-
ments (21).
Interaction of NDUFAF5 with Subunit NDUFS7 of Complex
I—By SILAC and quantitative mass spectrometry experiments
with an inducible tagged version of NDUFAF5, six proteins
were found to be associated with statistical significance with
NDUFAF5 (Fig. 2A and supplemental Table S1). The complex I
subunit, NDUFS7, was enriched to the greatest extent, and the
complex I subunit NDUFAB1, iron-sulfur cluster scaffold ho-
molog NFU1, stroma cell-derived factors 2 and 2-like (SDF2
and SDF2L1, respectively), and DNAJ homolog subfamily B
member 11 (DNAJB11), to lesser degrees. Control experiments
were conducted in parallel with an inducible and tagged version
ofMETTL12, amember of the 7-strandmethyltransferases of
unknown function. Complementary SILAC experiments were
performed with a tagged version of NDUFS7 and with a tagged
version of the complex I subunit NDUFB3 as a control. They
showed that NDUFAF5, NDUFAF3, and NDUFAF4 (both
assembly factors for complex I) and -aminoadipic semialde-
hyde dehydrogenase (ALDH7A1) were associated significantly
with NDUFS7 (Fig. 2B and supplemental Table S2), and that no
proteinwas associated significantly withNDUFB3.However, in
both of these independent and complementary experiments,
NDUFS7 and NDUFAF5 were the only two proteins that were
associated consistently with each other.
Suppression of NDUFAF5 and the Hydroxylation of Arg-73 in
NDUFS7—Subunit NDUFS7 contains no post-translationally
methylated amino acids, but the conserved arginine residue
(residues 73 and 77 in the human and bovine complexes,
respectively) is completely hydroxylated (25). Therefore, the
possibility that NDUFAF5 might catalyze the introduction of
this modification was investigated as follows. In HEK cells
where tagged-NDUFS7 was being overexpressed, the expres-
sion of NDUFAF5 was suppressed transiently, and in a control
experiment the expression of the assembly factor NDUFAF7
was suppressed. It was found that the transcripts forNDUFAF5
and NDUFAF7 had been suppressed by 60–70% relative to
controls, and these levels of suppression had been maintained
throughout the experiment (Fig. 3A). In untreated cells where
NDUFS7 had been overexpressed, about 50% of its Arg-73 was
hydroxylated, and treatment with negative control siRNA did
not alter this level appreciably (Fig. 3B). However, suppression
of the expression of NDUFAF5 with 50 nM siRNA reduced
the relative hydroxylation of Arg-73 by 49%, whereas suppres-
sion of NDUFAF7 had no impact on hydroxylation of this res-
idue (Fig. 3B). When the expression of NDUFAF5 was sup-
pressed with a higher 100 nM concentration of siRNA the
relative level of hydroxylation was reduced to 41%. Suppression
of NDUFAF7with 100 nM siRNA also reduced the relative level
of hydroxylation of Arg-73 to a lesser extent (58%), but this
reduction is the expected consequence of the extensive disrup-
tion of the assembly of complex I accompanying the suppres-
sion of expression of this assembly factor. The identities of the
unmodified and hydroxylated forms of the AspN peptide (res-
idues 66–79) containing Arg-73 were confirmed by fragmenta-
tion of the triply charged ions m/z 541.29 and 546.62, respec-
tively (Fig. 3, C and D).
In cells where expression of NDUFAF5 had been suppressed,
the extent of methylation of Arg-85 in NDUFS2 was un-
changed, whereas the dimethylation was reduced progressively
in cells where NDUFAF7 had been depleted (data not shown),
as reported before (19).
Suppression of NDUFAF5 and Assembly and Function of
Complex I—When the expression of NDUFAF5 was sup-
pressed, both NDUFS7 and ND1, representing the peripheral
and membrane arms of complex I, were lost progressively
(Fig. 4A), indicating that the participation of NDUFAF5 in
the pathway of assembly of complex I affects both arms of the
complex. Because endogenous NDUFS7 becomes degraded in
these circumstances, the effect of suppression of expression of
NDUFAF5 on the hydroxylation of Arg-73 in NDUFS7 was
investigated in cells where NDUFS7 was overexpressed (Fig. 3).
Although the level of subunit NDUFS2, a component of the
peripheral arm, remained constant over the course of the
experiment (Fig. 4A), the level of intact complex I was reduced
progressively relative to control cells (Fig. 4B), indicating that
some or all of the NDUFS2 being monitored had not been
incorporated into the complex. The reduction in the level of
complex I associated with the depletion of NDUFAF5 (Fig. 4B)
was accompanied by the accumulation of a sub-complex with
an apparent molecular mass of 370 kDa, containing subunit
NDUFB8, a component of the membrane arm of complex I. At
the same time, another sub-complex observed in control cells
with an apparent molecular mass of 200 kDa, containing the
peripheral arm subunit NDUFS2 was reduced.
Subunit NDUFB3 contains methylated histidine residues,
and therefore it was considered as a potential substrate for
FIGURE 1. Sub-cellular location of NDUFAF5. Human 143B cells were transfected with a plasmid encoding tagged NDUFAF5, and immunocytometry was
performed 24 h later. Part A, cell nucleus stained with DAPI (blue); part B, recombinant NDUFAF5 detected with an anti-FLAG antibody, plus goat anti-mouse
Alexa Fluor 488 (green); part C, mitochondria stained with MitoTracker (red); part D, merged areas of parts A–C.
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NDUFAF5. However, depletion of these two proteins impacted
on different stages of the assembly of complex I. The suppres-
sion of NDUFAF5 affected the biogenesis of complex I at an
early stage of assembly, whereas the depletion of NDUFB3 did
not influence the formation of the early stage 200 kDa sub-
complex identified with antibodies against NDUFS2 and
assembly factor NDUFAF3 (Fig. 5). Additionally, NDUFB3 is a
subunit of sub-complex I, which represents the region of the
membrane arm of complex I that lies distal from its peripheral
arm (3, 14); this part of the complex is added at a later stage in
the assembly process (18). Depletion of NDUFB3 had the effect
of reducing the level of the intact complex (Fig. 5).
The effect of suppression of expression of NDUFAF5 on cel-
lular energetics was examined by monitoring the OCR. Over
the course of the experiment, transcripts for NDUFAF5 were
reduced to about 30% of the control level (Fig. 6A). At 120 h, the
suppression of NDUFAF5 was associated with a reduction of
the E/L ratio (see Fig. 6B). At 192 h, the E/L ratio had been
reduced further, and in these cells theOCR linked to complexes
I and III was reduced (Fig. 6C). These effects are due to the
disruption of the assembly of complex I and the potential sec-
ondary adverse effect of the depletion ofNDUFAF5on complex
IV activity (21, 23). It has been noted before (21, 23) that the
impact on complex IVmay be cell/tissue specific, and although
the reason for the effect is unknown it could be due to impair-
ment of formation or stability of a supercomplex for example.
Discussion
NDUFAF5 as an Arginine Hydroxylase—The hydroxylation
of arginine residues in proteins is a rare post-translationalmod-
ification, and, other than NDUFS7, only three instances have
been reported. First, a single 3-hydroxyarginine residue has
been found at position-81 of the L16 component of the 50S
subunit of the Escherichia coli ribosome (26). Second, numer-
ous 4-hydroxyarginine residues are present in protein compo-
nents of adhesive plaques of the mussel Mytilus edulis (27).
Third, a single 4-hydroxyarginine residue has been identified in
the large subunit of carbon monoxide dehydrogenase (CO-
DHL) from Hydrogenophaga pseudoflava (28). From the point
of view of the current investigation, the modification of CO-
DHL is highly significant because the sequence around the site
of hydroxylation in NDUFS7 is related to the sequence around
the site of hydroxylation in CO-DHL (Fig. 7A). In the structure
of CO-DHL, this sequence, which also includes the active site
cysteine, forms a loop followed by an -helix (28) (Fig. 7B). In
bacterial andmitochondrial complexes I, the arginine residue is
conserved, but the bacterial residue is not modified (25). There
is no evidence that this arginine in prokaryotic complex I has a
role in enzyme assembly or activity. NDUFS7 is the equivalent
of bovine subunit PSST, fungal subunit NUKM and bacterial
subunit NuoB/Nqo6. In none of the complex I structures was
there unambiguous electron density for the loop (5, 9, 15), pos-
sibly because it is mobile. In bacterial complexes I, the corre-
sponding arginine residue in subunit Nqo6 lies close to a tun-
nel, also involving subunits Nqo8 (ND1) and Nqo4 (NDUFS2),
in the membrane and peripheral arms of the complex respec-
tively, where the oxidized coenzyme Q is thought to bind and
accept electrons from iron-sulfur cluster N2 (9). The restricted
access to the residue via the tunnel in the mitochondrial
enzyme makes it most unlikely that the hydroxylation could
occur in this assembled state, in agreement with the proposal
that the modification occurs during assembly of the complex,
and before formation of the tunnel.
The finding that a member of the family of SAM-dependent
7-strand methyltransferases is a hydroxylase has a precedent.
While many protein and small molecule hydroxylases belong
either to the 2-oxoglutarate dependent dioxygenases (29, 30),
FIGURE2.ProteinsassociatedwithNDUFAF5andNDUFS7.Parts A andB, quantitativemass spectrometryofNDUFAF5andNDUFS7andassociatedproteins,
respectively. SILAC-labeledHEK293Tcells overexpressing taggedandcontrol proteinsweregrown, and then taggedandassociatedproteinswerepurifiedand
combined. A, tagged-NDUFAF5 and differentially labeled control cells overexpressing tagged-METTL12, and, in B, tagged-NDUFS7 and differentially labeled
control cells overexpressing tagged-NDUFB3. The experiments were performed in both labeling orientations. Part A, f, NDUFAF5 and METTL12;●, proteins
significantly associated in both experiments with NDUFAF5, and E, with METTL12;, 312 insignificantly associated proteins, and 8 associated significantly in
one orientation of labeling only; DCD, exogenous contaminant (dermcidin). Part B,f, NDUFS7, andNDUFB3;●, proteins significantly associatedwith NDUFS7
in both experiments; , 203 insignificantly associated proteins, and E, 10 proteins significantly associated with overexpressed NDUFS7 in one labeled-
orientation only; Œ, complex I subunits NDUFS2, NDUFS3, NDUFS8, and NDUFA5; the larger black dotted ellipse encompasses 26 other subunits of complex I,
and the smaller ellipse contains four subunits of complex III (see supplemental Table S2).
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where the atomsof dioxygen are incorporated into two substrates,
and not into water, or to the cytochrome P450 enzymes (31),
which reduce one atom of dioxygen to a hydroxyl group and the
other to water, another mono-oxygenase, RdmB, from Strepto-
myces purpurascens introduces a hydroxyl moiety into the
10-position of the anthracycline component of the anti-cancer
drug aclacinomycin, or aclarubicin (32, 33). Like NDUFAF5,
RdmB belongs to the family of SAM-dependent 7-strand
methyltransferases, and is structurally very similar to the
methytransferase DnrK (the r.m.s.d. of superimposed main
chain atoms is 1.14 Å) (34, 35). However, RdmB has no meth-
yltransferase activity, and SAM acts as a cofactor in the process
of hydroxylation (32, 33). Remarkably, the insertion of a single
serine residue converted DnrK from a methyltransferase to a
hydroxylase, causing the methyl group of SAM to point in a
direction not suitable for methyl transfer (36). The positive
charge of SAM is a crucial feature of the hydroxylation reaction
as S-adenosylhomocysteine cannot substitute for SAM. Other
requirements are dioxygen and a reductant such as glutathione.
The three-dimensional structure of RdmB has three do-
mains. The N-terminal domain is involved in the formation of
homo-dimers, the middle domain is mainly -helical, and the
C-terminal domain contains a Rossmann fold of five -strands
with associated -helices on both sides, plus two additional
-strands to complete the characteristic 7-strand fold (34).
The substrate binds between the middle and C-terminal
domains, and SAM to the C-terminal domain. The sequence of
the region of RdmB containing the 7-strand fold is related to
the C-terminal region of NDUFAF5, and the predicted second-
ary structure of NDUFAF5 resembles the known secondary
structure of RdmB over this region (Fig. 8). On this basis, it is
likely that the mechanism of hydroxylation of Arg-73 in
NDUFS7 by NDUFAF5 is similar to the mechanism of hydrox-
ylation catalyzed by RdmB.
FIGURE 3. Effect of suppression of expression of NDUFAF5 on hydroxylation of Arg-73 inNDUFS7. Part A, HEK293T cells overexpressing tagged-NDUFS7
were transfected twice at 0 and72h,with 50or 100nM siRNA specific forNDUFAF5 (-FAF5), NDUFAF7 (-FAF7), orwith anegative control siRNA. Transcript levels
were examined at 48 and 120 h and are normalized to endogenous -actin. The error bars show the standard deviation. Part B, mass spectrometric analysis of
the hydroxylation of Arg-73 in NDUFS7. The histograms are derived from the extracted ion chromatograms for the m/z values of the hydroxylated or
non-hydroxylated Asp-N peptide (residues 66–79) from NDUFS7. The numbers correspond to the level of hydroxylation relative to a value of 1.0 for the
untreated control. Parts C andD, fragmentation spectra of triply charged ions,m/z 541.29 andm/z 546.62, representing unmodified andhydroxylated versions
of the AspN peptide (resides 66–79) from human NDUFS7. In the insets, fragment ions are mapped onto the amino acid sequence.
Assembly of Human Complex I
14854 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 28•JULY 8, 2016
Role of NDUFAF5 in the Assembly ofMitochondrial Complex
I—In humanmitochondria, complex I is assembled from forty-
four different proteins emanating from two genomes; the com-
plex contains two copies of subunit NDUFAB1 and single cop-
ies of all other subunits (5). Thirty-seven of them are encoded
and transcribed in the nucleus of the cell; they are translated in
the cytoplasm and are imported into the organelle. The remain-
ing subunits are encoded in mitochondrial DNA, and are the
seven hydrophobic proteins that provide the core of the mem-
brane arm of the complex. The assembly of human complex I
proceeds via sub-complexes (16, 17), built up from specific sub-
units with the participation of exogenous proteins, known as
assembly factors (13, 18) (Fig. 9). At least thirteen such assem-
bly factors have been identified. Nine of them (NDUFAF1–4,
ACAD9, C3orf1, ECSIT, FOXRED1, and TMEM126B) bind to
specific sub-complexes in the assembly pathway (13, 37–42),
but their exact molecular roles are unknown. Mutations in
another group of assembly factors for complex I not found in
associationwith assembly intermediates, lead to human disease
associated with incompletely assembled complex I (21, 43–45).
They include NUBPL and NDUFAF6. NUBPL probably partic-
ipates in the incorporation of iron-sulfur clusters into the com-
plex (46) and NDUFAF6may help to stabilize the sub-complex
of the peripheral arm that interacts with themembrane subunit
ND1 (47). A twelfth assembly factor NDUFAF7 is a 7-strand
methyltransferase that dimethylates Arg-85 in the NDUFS2
subunit (19, 20). NDUFAF5 is a known thirteenth assembly
factor, and the experiments described here show that its role in
the process of assembly is to hydroxylate residue Arg-73 in
subunit NDUFS7. They provide no support for an alternative
proposal that during assembly of complex I, NDUFAF5methy-
lates histidines in the N-terminal region of subunit NDUFB3.
According to current models (see Fig. 9), a 315-kDa sub-
complex is the earliest assembly intermediate involving com-
ponents of bothmembrane andperipheral arms. It comprises at
least eight nuclear encoded subunits (NDUFS2, NDUFS3,
NDUFS7, NDUFS8, NDUFA3, NDUFA5, NDUFA8, and
NDUFA13) plus one mitochondrial-DNA encoded subunit
ND1 and three assembly factors (NDUFAF3, NDUFAF4, and
C3orf1). The stages preceding the formation of this sub-com-
plex involve the initiation of the assembly of the peripheral arm
by NDUFS2, NDUFS3, and NDUFA5 joining with a NDUFS7-
NDUFS8 sub-complex. A 200-kDa sub-complex containing at
least NDUFS2 and assembly factor NDUFAF3 is dependent on
NDUFAF5 (Figs. 4 and 5). Previously, the formation of a 200-
kDa sub-complex was shown to be disrupted by depletion of
assembly factor NDUFAF3 with similar results for assembly
factors NDUFAF4, NDUFAF5, and NDUFAF6 (47). Residue
Arg-85 in NDUFS2 is methylated by a transient interaction
with NDUFAF7 at some point in the formation of the early
peripheral arm sub-complex (19). In contrast, NDUFAF5 in the
process of hydroxylating NDUFS7, is found associated with
assembly factors NDUFAF3 and NDUFAF4 (Fig. 2B), as noted
before (48). They are likely to participate in the formation of the
FIGURE 4. Suppression of expression of NDUFAF5 and assembly of com-
plex I. Human 143B cells were transfected three times with either negative
control siRNA or siRNA specific for NDUFAF5, denoted by a and b, respec-
tively, and samples ofmitoplasts and innermembranesweremade 48 h after
each transfection. Parts A and B, mitoplasts and inner mitochondrial mem-
brane proteins, respectively, fractionated, in A by SDS-PAGE and, in B, by
BN-PAGE. In part A, samples taken from three duplicate gels were Western-
blottedwith antibodies against subunits NDUFS2, NDUFS7, and ND1 of com-
plex I, and one of them, employed as a loading control, was stained with
Coomassie Blue dye, after Western blot analysis; in part B, membranes were
probed with antibodies against the peripheral arm subunit NDUFS2, and
membrane armsubunitNDUFB8, andprobeda second timewith an antibody
against complex II subunit SDHB as a loading control, shown for the 192 h
sample. CI-980 kDa, mature complex I; CI-200 kDa,370 kDa,550 kDa, sub-
complexes of complex I; CII-130 kDa, complex II. The control cell results
(denotedby the letter a inA andB) havebeenpresentedpreviously in another
context (19).
FIGURE 5. Effect of transient suppression of expression of NDUFB3 and
NDUFAF5 on the assembly of complex I. Samples were prepared at 192 h
fromhuman143Bcells that hadbeen transfected three times at 72-h intervals
with (a), negative control siRNA or (b and c), siRNA specific for NDUFB3 and
NDUFAF5, respectively. Inner mitochondrial membrane proteins were frac-
tionated by BN-PAGE, Western-blotted and probed with antibodies against
the peripheral arm subunit NDUFS2 and assembly factor NDUFAF3. Antibod-
ies against complex III (UQCRC1) and complex IV (COX5B) were used as load-
ing controls on NDUFS2 and NDUFAF3 blots, respectively. CI, complex I; CIII2,
complex III dimer; CIV, complex IV; CIII2CIV, assembly of complex III dimer
and complex IV; CI-200 kDa, complex I sub-complex.
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early 200 kDa peripheral arm sub-complex formed only from
NDUFS7, NDUFS2, NDUFS3, NDUFS8, and NDUFA5 (Fig. 9),
as indicated by the preferential association of the four latter
subunits with tagged-NDUFS7 (Fig. 2B). However, the precise
point at which NDUFAF5 hydroxylates NDUFS7 in this pro-
cess is not known. There is no indication in the data for a direct
interaction between NDUFAF5 and MT-ND1, which partici-
pates in the formation of the 315 kDa intermediate (see Fig. 9).
Therefore, NDUFAF5 must dissociate before its formation, as
its presencewould impede the association of the peripheral arm
sub-complex with MT-ND1.
Experimental Procedures
Protein Analyses—Protein concentrations were determined
by the bicinchoninic acidmethod. Samples containing proteins
were analyzed by SDS-PAGE in 10–20% polyacrylamide gradi-
ent gels. Proteins were detected by staining with Coomassie
Blue dye.
Cell Culture—Human 143B osteosarcoma cells (ATCCnum-
ber CRL8303) were grown at 37 °C in Dulbecco’s Modified
Eagle’s Medium (DMEM) containing 25 mM glucose and sup-
plemented with fetal calf serum (10% v/v), penicillin (100 units/
ml), and streptomycin (0.1 mg/ml) under an atmosphere of 5%
carbon dioxide. The serum in the medium for parental human
embryonic kidney cells HEK293T and HEK293T cells express-
ing Flag-Strep-tag II-fusion proteins was tetracycline-free, and
the medium included blasticidin (15 g/ml) and zeocin (100
g/ml), or blasticidin (15 g/ml) and hygromycin (100 g/ml).
Protein Expression and Purification—The cDNA for human
NDUFAF5 (Source Bioscience, Nottingham, UK) was ampli-
fied by polymerase chain reaction. It was cloned into the
inducible expression vector pcDNA5/FRT/TO (Invitrogen)
with sequences encoding C-terminal FLAG and StrepII tags.
The cDNAs for human NDUFS7, METTL12, and NDUFB3
(Source Bioscience) were amplified and cloned in a similar way.
The plasmid for NDUFAF5 was transfected into human 143B
cells, and the subcellular location of the protein was examined
by confocal microscopy (19). The transfection of HEK293T
FIGURE 6. Suppression of expression of NDUFAF5 and oxygen consumption. Expression of NDUFAF5 in 143B cells was suppressed three times with siRNA
at 72 h intervals. Part A, effect on levels of transcripts for control and NDUFAF5-depleted cells (white and hatched histograms, respectively) 48 h after each
suppression. The values are normalized to endogenous-actin, and error bars show the standard deviation. Parts B and C, oxygen consumption rates (OCR) of
negative control and NDUFAF5 siRNA-treated cells (white and shaded histograms, respectively) 120 h (B) and 192 h (C) after the first transfection, respectively.
OCR was normalized to cell number. Rates were measured after successive additions of 2-deoxyglucose, rotenone, duroquinol, and antimycin, or 2-deoxyg-
lucose, oligomycin, carbonylcyanide p-(trifluoromethoxy)-phenylhydrazone (FCCP), and a combination of rotenone and antimycin A. The OCR for complex I
represents the rate for 2-deoxyglucose-treatedcellsminus the rate for rotenone-treatedcells, and those for complex III are theOCRvalues forduroquinolminus
antimycin A. The E/L ratio (FCCP/oligomycin) is an index of the maximum oxygen consumption capacity of the electron transport system (E) relative to the
magnitude of uncoupled respiration (L).
FIGURE 7. Relationship between sites containing a hydroxylated-argi-
nine residue in NDUFS7 and carbon monoxide dehydrogenase from
H. pseudoflava. Part A, alignment of sequences of residues 69–82 of human
NDUFS7, and the active site loop of the carbon monoxide dehydrogenase
large chain (CO-DHL; residues 380–393), with hydroxylated arginine residues
in blue. In CO-DHL, the next residue (red) is the catalytically essential Cys-385.
The symbols *, :, and . denote identical, strongly conserved, and weakly con-
served residues, respectively; part B, the structure of the loop and the follow-
ing -helix containing residues 380–393 of CO-DHL. In the structures of bac-
terial and bovine complex I, the equivalent regions in the orthologs of
NDUFS7 were not resolved.
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Flp-In T-REx cells with other plasmids, cell selection, and the
preparation of mitoplasts and samples of Strep-tag II affinity-
purified proteins, were performed as described previously (49).
Protein Quantitation with SILAC—Human HEK293T cells
expressing either tagged-NDUFAF5 or NDUFS7, and with a
potential mitochondrial protein methylase calledMETTL12 or
with NDUFB3 as respective controls, were grown in “heavy”
DMEM containing arginine and lysine isotopically labeled with
15N and 13C, and in “light” DMEM containing 14N and 12C
arginine and lysine (Sigma) (50). These media were supple-
FIGURE 8. Alignment of the C-terminal regions of the sequences of RdmB from S. purpurascens and human NDUFAF5. The N-terminal regions (not
shown) are unrelated.White letters on dark gray andmid-gray indicate identical and conserved residues, respectively, and black letters on light gray are weakly
conserved residues. The secondary structural elements of the 7-strand SAM binding domain of RdmB are shown above its sequence, and the predicted
secondary structure of NDUFAF5 is shown below. Helices and -strands are blue and red, respectively. The second helix of RdmB (residues 164–167) is a
310-helix, and the others are-helices. In RdmB, the 7-strandmethyl-transferase-fold consists of-sheets 1–7 and intervening-helices A–E. RdmB lacks helix
C, found between -strands 3 and 4 in some family members. The other -helices lie outside the 7-strand fold and contain residues involved in substrate
binding. Black dots and inverted black triangles, respectively, denote amino acids involved in binding SAM, and in binding substrates and products.
FIGURE 9. Participation of NDUFAF5 in the pathway of assembly of human complex I. Assembly factors associated stably with sub-complexes in the
pathway are indicated. Hydroxylation of NDUFS7 by NDUFAF5 occurs at an early stage. The scheme is derived from an earlier version (19), and it is not known
whether the 200-kDa sub-complex is associated with the membrane or not, as indicated. The 200-kDa sub-complex joins with membrane subunit ND1 and
assembly factor C3orf1, plus subunits NDUFA3, NDUFA8, and NDUFA13 to form the 315-kDa membrane-bound sub-complex (13).
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mented with penicillin (100 units/ml), streptomycin (0.1
mg/ml), proline (200 mg/liter), and dialyzed fetal calf serum
(10% v/v). The cell population was doubled at least seven times.
The expression of the tagged protein was induced for 24 h with
doxycycline. Portions (ca. 10 mg protein) of the heavy and light
cells were collected, mitoplasts were prepared, and proteins
were purified from them by affinity chromatography. They
were mixed and fractionated by SDS-PAGE, and proteins in
slices taken from gel lanes were digested with trypsin (51).
Tryptic peptideswereanalyzedbymass spectrometry (19,49), and
proteins were identified and quantitated with MaxQuant and
Andromeda (52, 53). Bioinformatics and calculations of statistical
significancewereperformedwithPerseus (54).Eachmass spectro-
metric ratio was based on duplicate SILAC experiments. Proteins
that were associated in both experiments involving inducible and
tagged versions ofNDUFS7 andNDUFAF5were considered to be
significant binding partners.
Suppression of Expression—Transcripts for NDUFAF5 and
NDUFB3 were suppressed transiently in 143B cells with 30 nM
siRNA (Silencer Select siRNA, Life Technologies, Paisley, UK).
A negative control siRNA (Allstars Negative Control siRNA;
Qiagen, Manchester, UK) was used at the same concentration.
Three successive transfections were performed at 72-h inter-
vals. Transcript levels (normalized to endogenous -actin)
were determined by quantitative real-time PCRwith a Taqman
gene expression assay (Life Technologies) on cDNA prepared
with a Cells-to-CT kit (Life Technologies). Samples of cells
were taken 48 h after each transfection, and enriched either for
mitoplasts or inner mitochondrial membrane proteins (19, 55).
Tagged NDUFS7 was overexpressed in HEK293T cells, and
transcripts of NDUFAF5 or NDUFAF7 (used as a control) were
suppressed transiently with 50 nM or 100 nM siRNA. Two suc-
cessive transfections were performed at 72-h intervals, and 24 h
after the second transfection, expression of tagged proteins was
induced with doxycycline. Another 24 h later, proteins were
affinity-purified, fractionated by SDS-PAGE, and detected with
Coomassie Blue dye. Stained protein bands were digested with
either trypsin or protease AspN, and subjected tomass spectro-
metric analysis.
Analysis of Hydroxylation of NDUFS7—Tryptic or AspN
digests were analyzed in an LTQOrbiTrap XL-mass spectrom-
eter (Thermo Scientific). Peptides were fragmented by collision
induced dissociation with nitrogen, or by electron transfer dis-
sociation, as described previously (19, 49). The effect of the
suppression of expression of NDUFAF5 on the hydroxylation
of NDUFS7 was followed by analysis of the AspN peptide DRF-
GVVFRASPRQS (resides 66–79) where Arg-73 is hydroxy-
lated. The monoisotopic m/z values for the unmodified and
hydroxylated peptides are 811.4315 (M2H)2 and 541.2901
(M3H)3, and 819.4290 (M2H)2 and 546.6217 (M
3H)3, respectively.
Effect of Depletion of NDUFAF5 on the Assembly of Complex
I—Mitoplasts and inner mitochondrial membranes were pre-
pared from 143B cells where NDUFAF5 had been depleted, and
from control cells. The proteins were fractionated by SDS-PAGE
and by blue native PAGE, and transferred by electrophoresis to
polyvinylidenedifluoridemembranes asdescribedpreviously (19).
The levels of proteins, and the influence of suppression of expres-
sion of NDUFAF5 on the assembly of complex I, were assessed
with antibodies against subunits NDUFS2 (Abcam ab96160),
NDUFS7 (Abcam ab127051), NDUFB8 (Sigma HPA003886),
and MT-ND1 (chicken anti-peptide antibody prepared against
AETNRTPFDLAEGE; Agrisera, Vannas, Sweden), assembly
factor NDUFAF3 (Sigma HPA035377), the SDHB subunit of
complex II (Sigma HPA002868), UQCRC1 subunit of complex
III (Sigma HPA002815) and COX5B subunit of complex IV
(Sigma HPA034517).
Measurement of Respiration—The rate of consumption of
oxygen (OCR) of 143B cells where NDUFAF5 had been
depleted, and of control cells, was measured in an XF24 extra-
cellular flux analyzer (Seahorse Biosciences, North Billerica) as
described before (19). The assay medium was DMEM base for-
mulation (Sigma) plus NaCl (1.85 g/liter), 2 mM glucose, 2 mM
GlutaMax (Life Technologies), 1 mM pyruvate, phenol red (15
mg/liter), and 20 mM HEPES (pH 7.4). Cells in assay medium
were equilibrated for 1 h at 37 °C in air. Then basal OCR was
measured and either 2-deoxyglucose (20 mM), rotenone (600
nM), duroquinol (627M), and antimycin (600 nM), or 2-deoxy-
glucose (20 mM), oligomycin (100 nM), carbonylcyanide p-(tri-
fluoromethoxy)phenylhydrazone (500 nM) and a combination
of rotenone (600 nM) and antimycin A (600 nM), were added
sequentially. Complex I-dependent OCR was determined by
subtraction of rotenone-inhibited OCR values from values
obtained after the addition of 2-deoxyglucose; complex III-de-
pendent OCR was corrected by subtraction of antimycin A-in-
hibited OCR values from values obtained after the addition of
duroquinol. p values for the OCR were calculated with a paired
Student’s t test.
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